Multidisciplinary Oncology Updates in Precision Medicine, Immunotherapy, Hematologic Malignancies & Solid Tumors

Cancer care continues evolving at extraordinary speed as advances in genomics, immunotherapy, molecular diagnostics, cellular therapy, and precision oncology reshape how clinicians diagnose and treat malignancies across every stage of disease. The Cleveland Clinic 2nd Annual Cancer Conference 2026 delivers a broad, multidisciplinary review of contemporary oncology practice through expert-led discussions covering hematologic malignancies, solid tumors, targeted therapies, palliative medicine, artificial intelligence, and emerging cancer technologies.

Built around the theme “Innovations in Multidisciplinary Care,” this conference brings together specialists from medical oncology, hematology, radiation oncology, surgical oncology, precision medicine, and supportive care to examine how modern cancer management increasingly depends on integrated, personalized treatment strategies.

This educational package includes:

• 37 Video Lectures
• 1 PDF File
• Total Size: 5.02 GB
• Release Date: March 2, 2026

Held at the Margaritaville Hollywood Beach Resort in Florida and simultaneously streamed online, the conference reflects the growing complexity of modern oncology, where treatment decisions increasingly require collaboration across multiple specialties and evolving molecular technologies.

The Shift Toward Precision Oncology

One of the central themes throughout the conference is the continued transition from traditional organ-based cancer treatment toward precision-driven oncology.

Modern oncology increasingly incorporates:

• Genomic profiling
• Minimal residual disease (MRD) monitoring
• Molecular biomarkers
• Targeted therapies
• Cellular immunotherapy
• AI-assisted clinical decision-making

The course repeatedly emphasizes that many cancers once managed uniformly are now stratified according to:

• Molecular signatures
• Driver mutations
• Tumor microenvironment characteristics
• Immune responsiveness
• Treatment resistance pathways

This shift has fundamentally changed both prognosis assessment and therapeutic sequencing.

Hematologic Malignancies & Cellular Therapy

The hematologic oncology sessions provide updates on:

• Myeloproliferative neoplasms
• Myelodysplastic syndromes (MDS)
• Acute myeloid leukemia (AML)
• Multiple myeloma
• AL amyloidosis
• CAR-T cell therapy

The discussions examine how advances in molecular genetics and immune-based therapies are rapidly transforming hematologic cancer management.

One recurring challenge in hematologic oncology involves balancing:

• Disease control
• Treatment toxicity
• Transplant eligibility
• Long-term quality of life
• Relapse prevention

particularly in older or medically complex patients.

The CAR-T and cellular therapy lectures explore the expanding role of engineered immune therapies in refractory malignancies and the evolving management of treatment-related complications.

Genomics, AI & Personalized Cancer Care

The precision oncology sessions focus heavily on emerging technologies.

Topics include:

• Genetic testing strategies
• Minimal residual disease monitoring
• Artificial intelligence in oncology
• Precision oncology case discussions
• Personalized therapeutic planning

MRD monitoring has become increasingly important because it allows clinicians to detect microscopic residual disease long before radiographic relapse becomes apparent.

The AI discussions explore how machine learning may influence:

• Imaging interpretation
• Treatment prediction
• Workflow optimization
• Clinical trial matching
• Prognostic modeling

At the same time, the course appropriately acknowledges that integrating AI into oncology practice still presents important ethical, logistical, and validation challenges.

Lung Cancer: Rapidly Changing Treatment Paradigms

The lung cancer sessions review:

• Early-stage NSCLC management
• Locally advanced disease
• Metastatic NSCLC
• Small cell lung cancer
• Surgical challenges after neoadjuvant therapy

Thoracic oncology continues evolving rapidly through:

• Immunotherapy combinations
• Molecular-targeted agents
• Neoadjuvant systemic therapy
• Biomarker-driven treatment selection

Clinical decision-making becomes increasingly complex when determining:

• Surgical timing
• Adjuvant therapy
• Molecular testing priorities
• Sequencing of systemic treatment

particularly in patients with multiple targetable mutations or mixed histologic features.

Supportive Oncology & Palliative Medicine

The palliative care sessions are especially valuable because modern oncology increasingly recognizes symptom management as a core component of comprehensive cancer treatment.

Topics include:

• Cancer cachexia
• Fatigue management
• Neuropathy treatment
• Benzodiazepine use in oncology
• Integrative therapies such as acupuncture

The course appropriately emphasizes that supportive oncology is not limited to end-of-life care, but instead plays a major role throughout the cancer continuum.

In practice, many treatment-limiting complications arise not directly from cancer progression, but from:

• Nutritional decline
• Neuropathic toxicity
• Functional deterioration
• Psychological distress
• Symptom burden

Novel Therapies & Emerging Drug Platforms

The novel therapeutics section reviews several rapidly evolving treatment modalities, including:

• Antibody-drug conjugates (ADCs)
• RNA therapeutics
• Cellular therapies
• Organ-preservation strategies
• Clinical complete response (cCR) assessment

Antibody-drug conjugates have become one of the most important developments in modern oncology because they combine:

• Target specificity
• Cytotoxic delivery
• Improved therapeutic precision

The conference also explores how RNA-based therapeutics may reshape future cancer treatment through highly individualized molecular targeting approaches.

Gynecologic Oncology, Sarcoma & Melanoma

The solid tumor discussions address:

• Gynecologic cancers
• Sarcoma
• Melanoma
• Head and neck cancers
• Non-melanoma skin cancers

The sarcoma sessions are particularly relevant because sarcoma management often requires highly specialized multidisciplinary coordination involving:

• Surgical oncology
• Radiation oncology
• Molecular pathology
• Systemic therapy selection

Meanwhile, melanoma therapy continues evolving through increasingly sophisticated immunotherapy combinations and biomarker-guided approaches.

Gastrointestinal Oncology

The GI oncology sessions review:

• Early-onset colorectal cancer
• Gastroesophageal cancers
• Colorectal liver metastases
• Surgical innovation
• Shifting systemic therapy paradigms

Early-onset GI cancers have become an especially important area of investigation as incidence rises in younger populations without traditional risk profiles.

The lectures explore:

• Genetic predisposition
• Screening implications
• Molecular differences
• Evolving therapeutic strategies

Breast Cancer Updates

The breast oncology section examines:

• Breast surgery advances
• Radiation oncology updates
• Adjuvant systemic therapy
• Metastatic breast cancer treatment
• ADCs in advanced disease

Breast oncology remains one of the fastest-changing areas in cancer medicine due to rapid integration of:

• Targeted therapies
• HER2-directed treatment evolution
• Precision endocrine strategies
• Molecular profiling

Multidisciplinary Tumor Board Learning

A major strength of the conference is its extensive use of tumor board case discussions.

These sessions simulate real-world oncology decision-making where management often depends on integrating:

• Imaging findings
• Pathology interpretation
• Genomic data
• Surgical feasibility
• Radiation planning
• Systemic therapy options

The tumor board format highlights the reality that modern oncology care is increasingly collaborative rather than specialty-isolated.

Real-World Clinical Relevance

The conference repeatedly emphasizes:

• Evidence-based treatment integration
• Translating clinical trial data into practice
• Emerging technology adoption
• Personalized treatment planning
• Supportive care optimization

Importantly, the course avoids focusing solely on theoretical advances and instead addresses how clinicians apply rapidly changing oncology data in everyday patient management.

What’s Included

• 37 oncology video lectures
• 1 PDF file
• Total size: 5.02 GB
• Precision oncology and genomics discussions
• Hematologic malignancy updates
• Lung, breast, GI, gynecologic, and skin cancer sessions
• CAR-T and novel therapy reviews
• Multidisciplinary tumor board case discussions

Final Expert Perspective

Modern oncology is increasingly defined by precision medicine, multidisciplinary collaboration, and rapidly evolving therapeutic technologies. Molecular diagnostics, cellular therapies, immunotherapy combinations, and AI-assisted clinical tools are reshaping how clinicians approach both common and highly complex malignancies.

The Cleveland Clinic 2nd Annual Cancer Conference 2026 provides a broad and clinically relevant review of these developments through expert-led discussions spanning hematologic malignancies, solid tumors, supportive oncology, precision medicine, and emerging therapeutic strategies. For oncologists, hematologists, radiation specialists, and multidisciplinary cancer care professionals, this conference offers a valuable overview of contemporary oncology practice and future treatment directions.

Topics:

Comprehensive Immuno-Oncology Course

📌 Overview

The Memorial Sloan Kettering Cancer Center Foundations in Immunotherapy in the Oncology Population 2026 is a high-impact, evidence-based course focused on modern cancer immunotherapy and its clinical applications.

Delivered by experts from Memorial Sloan Kettering Cancer Center, this program provides a deep dive into checkpoint inhibitors, CAR T-cell therapy, and emerging immunotherapy strategies, with a strong emphasis on real-world toxicity management and patient outcomes .

📦 Course Details

• 🎥 23 Video Lectures (.mp4)
• 📝 23 Subtitles (.vtt)
• 📄 20 PDF Slides
• 💾 Total Size: 4.97 GB
• 📅 Date: January 28, 2026 (Online CME Program)

🎯 Target Audience

• Oncologists (medical, hematologic, solid tumor)
• Immunotherapy specialists
• Nurse practitioners & physician assistants
• Hospitalists and oncology care teams

🧠 What You’ll Learn

🧬 Core Immunotherapy Principles

• Immune system fundamentals (innate vs adaptive)
• Mechanisms of action of checkpoint inhibitors
• Key targets: PD-1, PD-L1, CTLA-4

🎯 Advanced Immunotherapy Modalities

• CAR T-cell therapy
• Bispecific antibodies (BiTEs)
• Tumor-infiltrating lymphocytes (TILs)
• Novel immune agonists

🧪 Clinical Applications Across Cancers

• Solid tumors (lung, breast, bladder, melanoma)
• Hematologic malignancies (leukemia, lymphoma, myeloma)
• Personalized treatment strategies

⚠️ Toxicity & Adverse Event Management

• Immune-related adverse events (irAEs)
• Cytokine release syndrome (CRS)
• Neurotoxicity (ICANS)
• Dermatologic and pulmonary toxicities

🧠 Precision Oncology & Biomarkers

• cfDNA and predictive biomarkers
• Patient selection and risk stratification
• Treatment response monitoring

🔬 Emerging Innovations

• Combination immunotherapy strategies
• Next-generation checkpoint inhibitors
• Expanding indications across tumor types

🎓 Learning Objectives

By completing this course, participants will be able to:

• Understand core mechanisms of cancer immunotherapy
• Apply immunotherapy strategies in clinical oncology
• Differentiate between various immunotherapeutic agents
• Manage toxicities and complications effectively
• Integrate CAR T-cell therapy into clinical practice

📚 Key Topics Included

• Mechanism of checkpoint blockade (PD-1 / PD-L1 / CTLA-4)
• CAR T-cell therapy and toxicity management
• Immunotherapy in leukemia, lymphoma, and solid tumors
• Pneumonitis and dermatologic toxicity management
• Small cell lung cancer innovations
• Bladder, breast, and GI cancer immunotherapy
• Bispecific antibodies in multiple myeloma
• Synovial sarcoma and T-cell therapies
• CRS, ICANS, and cytopenias
• Case-based Q&A discussions

⭐ Why This Course Stands Out

• ✔️ From world-leading cancer center (MSKCC)
• ✔️ Covers both fundamentals + cutting-edge therapies
• ✔️ Strong focus on real clinical toxicity management
• ✔️ Case-based learning with practical insights
• ✔️ Relevant for daily oncology practice

🚀 Clinical Value

This course is essential for clinicians who want to:

• Stay updated with rapidly evolving immunotherapy landscape
• Improve patient selection and treatment outcomes
• Reduce complications through early toxicity recognition
• Apply precision oncology approaches in practice

4. Topics

1. Advancing CAR T-Cell Strategies and Combination Therapies to Improve Outcomes in Gynecologic Malignancies

2. Advancing Leukemia Care Through Immuno-Oncology

3. Approaches to Immunotherapy-related Pneumonitis Management

4. Breast Oncology- Using cfDNA to Forecast Immunotherapy Treatment Outcomes

5. Checkpoint Inhibition as a Therapeutic Approach in Advanced Hodgkin Lymphoma

6. Clinical Approaches to Dermatologic Toxicity in Checkpoint Inhibitor Therapy

7. Discussion of Novel Checkpoint Inhibitors and Combination Therapy

8. Dostarlimab in MSI-High Gastrointestinal Cancers- Latest Data, Expansion Cohorts, and Basket Trial Insights

9. Evolving Treatment Paradigms- Immunotherapy in Advanced Bladder Cancer

10. IL-2-Stimulating Agents from Early Drug Development

11. Innovations in Small Cell Lung Cancer- DLL3 Agents and Adjuvant Durvalumab

12. Intrathecal Immunotherapy- A Novel Path in Treating Leptomeningeal Disease no video

13. Mechanism of Action of Checkpoint Blockade PD1, PDL1, CTLA-4

14. Melanoma Subtypes are a Microcosm for Immune Checkpoint Blockade Efficacy Across Oncology-

15. Neurotoxicity in CAR T-Cell Therapy- Recognition and Management

16. Overview of Adverse Events in the Cell Therapy Patient- A Discussion of CRS, ICANS, and Prolonged Cytopenias

17. Q&A and Discussion – 01

18. Q&A and Discussion – 02

19. Q&A and Discussion – 03

20. Q&A and Discussion – 04

21. Q&A and Discussion

22. Targeting Multiple Myeloma with Bispecific Immune-Modulating Agents

23. The Role of T-Cell Therapy in Standard Care for Synovial Sarcoma

24. Understanding Chimeric Antigen Receptor (CAR) T-Cell Therapy

Complete Immuno-Oncology Training | CAR T-Cell, Checkpoint Inhibitors & Toxicity Management

📌 Overview

The Memorial Sloan Kettering Cancer Center (MSKCC) Foundations in Immunotherapy 2026 is a comprehensive, evidence-based course designed to provide clinicians with a strong foundation in modern cancer immunotherapy.

This program covers the mechanisms, clinical applications, and toxicity management of immunotherapeutic agents across both solid tumors and hematologic malignancies, with a strong focus on real-world clinical practice.

Developed by experts at one of the world’s leading cancer centers, this course equips healthcare professionals with the knowledge needed to safely and effectively integrate immunotherapy into patient care .

📦 Course Specifications

• Videos: 23 HD lectures
• Subtitles: 23 VTT files
• PDFs: 20 supporting documents
• Total Size: 4.97 GB
• Format: On-demand learning
• Course Date: January 28, 2026

🎯 Target Audience

This course is ideal for:

• Medical oncologists
• Hematologists
• Oncology fellows and residents
• Nurse practitioners and physician assistants in oncology
• Multidisciplinary cancer care teams

🧠 What You Will Learn

🧬 Foundations of Immunotherapy

• Immune system mechanisms in cancer
• Innate vs adaptive immune responses
• Mechanisms of immune checkpoint blockade

💉 Checkpoint Inhibitors & Targeted Therapies

• PD-1, PD-L1, and CTLA-4 inhibitors
• Novel checkpoint inhibitors and combinations
• Clinical applications across multiple cancers

🧫 CAR T-Cell & Cellular Therapy

• CAR T-cell therapy principles and indications
• Patient selection and outcomes
• Toxicities: CRS, ICANS, cytopenias

🔬 Emerging Immunotherapies

• Bispecific antibodies (BiTEs)
• Tumor-infiltrating lymphocytes (TILs)
• Novel immune agonists and IL-2 agents

⚠️ Toxicity & Adverse Event Management

• Immune-related adverse events (irAEs)
• Pneumonitis, dermatologic toxicity, neurotoxicity
• Evidence-based management strategies

🧠 Clinical Application & Case-Based Learning

• Real-world case discussions
• Treatment planning and decision-making
• Personalized immunotherapy approaches

📚 Course Topics Include

• CAR T-cell therapy advancements
• Immunotherapy in leukemia, lymphoma, and myeloma
• Bladder, breast, melanoma, and GI cancers
• Small cell lung cancer immunotherapy
• Dermatologic and pulmonary toxicities
• Neurotoxicity and immune complications
• Bispecific immune-modulating agents
• Checkpoint inhibitor strategies

⚡ Key Benefits

• Master modern immunotherapy principles and applications
• Improve patient selection and treatment outcomes
• Recognize and manage serious immunotherapy toxicities
• Stay updated with latest oncology advances
• Apply knowledge directly in clinical practice

🚀 Why Choose This Course

• Developed by world-leading MSKCC experts
• Covers both foundations and advanced updates
• Focus on practical, real-world oncology care
• Essential for clinicians using or planning immunotherapy

💡 Clinical Value

This course is essential for healthcare professionals who want to:

• Integrate immunotherapy safely into oncology practice
• Improve outcomes in solid and hematologic cancers
• Stay current with rapidly evolving cancer treatments

🏥 About MSKCC

Memorial Sloan Kettering Cancer Center is one of the world’s leading cancer institutions, dedicated to advancing cancer treatment through research, education, and clinical excellence.

4. Topics

1. Advancing CAR T-Cell Strategies and Combination Therapies to Improve Outcomes in Gynecologic Malignancies

2. Advancing Leukemia Care Through Immuno-Oncology

3. Approaches to Immunotherapy-related Pneumonitis Management

4. Breast Oncology- Using cfDNA to Forecast Immunotherapy Treatment Outcomes

5. Checkpoint Inhibition as a Therapeutic Approach in Advanced Hodgkin Lymphoma

6. Clinical Approaches to Dermatologic Toxicity in Checkpoint Inhibitor Therapy

7. Discussion of Novel Checkpoint Inhibitors and Combination Therapy

8. Dostarlimab in MSI-High Gastrointestinal Cancers- Latest Data, Expansion Cohorts, and Basket Trial Insights

9. Evolving Treatment Paradigms- Immunotherapy in Advanced Bladder Cancer

10. IL-2-Stimulating Agents from Early Drug Development

11. Innovations in Small Cell Lung Cancer- DLL3 Agents and Adjuvant Durvalumab

12. Intrathecal Immunotherapy- A Novel Path in Treating Leptomeningeal Disease no video

13. Mechanism of Action of Checkpoint Blockade PD1, PDL1, CTLA-4

14. Melanoma Subtypes are a Microcosm for Immune Checkpoint Blockade Efficacy Across Oncology-

15. Neurotoxicity in CAR T-Cell Therapy- Recognition and Management

16. Overview of Adverse Events in the Cell Therapy Patient- A Discussion of CRS, ICANS, and Prolonged Cytopenias

17. Q&A and Discussion – 01

18. Q&A and Discussion – 02

19. Q&A and Discussion – 03

20. Q&A and Discussion – 04

21. Q&A and Discussion

22. Targeting Multiple Myeloma with Bispecific Immune-Modulating Agents

23. The Role of T-Cell Therapy in Standard Care for Synovial Sarcoma

24. Understanding Chimeric Antigen Receptor (CAR) T-Cell Therapy

Advanced Cellular Medicine & Immune Modulation

📦 Product Details

• Format: 8 Videos
• Duration: 10+ Hours of Content
• Modules: 2 Modules / 8 Lessons
• Access: On-demand
• Level: Advanced / Specialized Training

🧬 Program Overview

The SSRP Mastermind 4: Autoimmune Disease is an advanced clinical program focused on understanding and managing autoimmune disorders through a cellular medicine approach.

This course explores the biochemical, metabolic, and signaling pathways that drive immune dysregulation, offering clinicians a structured framework to interpret complex autoimmune conditions and apply innovative therapeutic strategies, including peptide-based interventions.

By integrating cellular metabolism, immune signaling, and clinical application, this program equips practitioners to deliver personalized, precision-based care for patients with autoimmune diseases.

🎯 Key Features

• Deep dive into cellular mechanisms of autoimmunity
• Focus on redox balance, metabolic pathways, and immune signaling
• Integration of peptide therapies and targeted interventions
• Case-based learning with clinical reasoning frameworks
• Emphasis on personalized and precision medicine approaches

📚 What You Will Learn

• Understand the pathophysiology of autoimmune diseases at the cellular level
• Analyze redox balance (NAD/NADH, oxidative stress) and its clinical implications
• Apply knowledge of key signaling pathways (mTOR, AMPK, AKT)
• Evaluate the role of gut health, microbiome, and environmental triggers
• Implement advanced treatment protocols using peptides and supplementation
• Develop individualized care plans for complex autoimmune patients

🧩 Core Topics Covered

⚙️ Cellular Metabolism & Energy Pathways

• Glycolysis and energy regulation
• Pentose phosphate pathway
• Lactate metabolism and cellular stress

🔬 Redox & Oxidative Stress

• NAD/NADH and NADP/NADPH balance
• Oxidative burden and inflammation
• Cellular resilience and repair

🧠 Immune Signaling Pathways

• mTOR, AMPK, and AKT pathways
• Nutrient sensing and immune activation
• Chronic inflammation mechanisms

🔄 Autophagy & Cellular Repair

• Cellular recycling processes
• Role in immune regulation and disease progression

🧬 Epigenetics & One-Carbon Metabolism

• DNA synthesis and methylation pathways
• Influence on immune function and disease expression

🌙 Circadian Biology & Immunity

• Timing and regulation of immune responses
• Impact on chronic disease and recovery

🦠 Gut–Immune Axis

• Microbiome and autoimmune triggers
• Barrier function and systemic inflammation

💊 Clinical Application

• Peptide therapies and targeted supplementation
• Lab interpretation and biomarker analysis
• Structuring treatment protocols for complex cases

🧠 Learning Approach

• Mechanism-based teaching
• Clinical reasoning and case organization
• Practical therapeutic frameworks
• Integration of science into real-world practice

👨‍⚕️ Target Audience

• Rheumatologists
• Immunologists
• Integrative and functional medicine physicians
• Internal medicine specialists
• Researchers and advanced healthcare professionals

🚀 Why This Course Stands Out

• Focus on root-cause, cellular-level understanding of autoimmune disease
• Combines biochemistry, immunology, and clinical application
• Emphasizes modern therapeutic strategies including peptides
• Ideal for clinicians managing complex, chronic autoimmune conditions
• Supports precision medicine and personalized care models

Complete Orthopaedic Surgery Video Library for Modern Musculoskeletal Practice

The AAOS Annual Meeting On Demand 2026 delivers one of the most comprehensive and clinically relevant orthopaedic surgery education libraries available today, bringing together advanced surgical lectures, subspecialty case discussions, procedural updates, and emerging innovations across the full spectrum of musculoskeletal medicine.

Developed by the American Academy of Orthopaedic Surgeons (AAOS), this extensive on-demand program captures the scientific sessions, expert panels, and surgical education presented during the 2026 AAOS Annual Meeting and transforms them into a powerful digital learning resource for orthopaedic surgeons, fellows, residents, and musculoskeletal specialists.

Rather than functioning as a simple conference recording archive, the program reflects the increasingly:

• Technology-driven
• Data-oriented
• Multidisciplinary
• Patient-centered

direction of modern orthopaedic surgery and reconstruction.

📦 Product Details

• 🎥 226 Videos (.mp4)
• 📄 226 PDF Files
• 📝 226 Subtitle Files (.vtt)
• 💾 Total Size: 166 GB
• 📅 Course Date: March 2–6, 2026
• 🌐 Access: On-demand
• 🧠 Level: Intermediate to Advanced Orthopaedic Surgery Education

🧠 Program Overview

Orthopaedic surgery has evolved dramatically over the last decade. Modern surgical success is no longer judged solely by implant survival or radiographic alignment. Instead, orthopaedic surgeons increasingly integrate:

• Precision surgical planning
• Rehabilitation science
• Biomechanics
• Patient-reported outcomes
• Enhanced recovery pathways
• Digital technologies
• Robotics
• Orthobiologics
• Long-term functional optimization

The AAOS Annual Meeting On Demand 2026 reflects these shifts across nearly every orthopaedic subspecialty.

The program emphasizes that contemporary orthopaedic practice now extends far beyond operative technique alone. Surgeons must balance:
✔️ Functional outcomes
✔️ Revision risk
✔️ Implant longevity
✔️ Soft tissue preservation
✔️ Patient comorbidities
✔️ Cost-effectiveness
✔️ Technological innovation
✔️ Long-term quality of life

This educational archive combines advanced procedural instruction with practical clinical reasoning and evidence-based treatment strategies.

🎯 Core Educational Focus

Participants gain comprehensive updates in:

• Adult reconstruction and arthroplasty
• Sports medicine and arthroscopy
• Spine surgery
• Orthopaedic trauma
• Shoulder and elbow reconstruction
• Foot and ankle surgery
• Orthopaedic oncology
• Pediatric orthopaedics
• Orthobiologics and AI-assisted surgery
• Practice management and surgeon wellness

The course repeatedly emphasizes:
✔️ Case-based learning
✔️ Decision-making under complexity
✔️ Surgical planning strategies
✔️ Modern rehabilitation integration
✔️ Technology-enhanced orthopaedic care

🦿 Advanced Arthroplasty & Revision Reconstruction

Adult reconstruction remains one of the largest components of the meeting.

Extensive sessions cover:

• Total knee arthroplasty (TKA)
• Total hip arthroplasty (THA)
• Revision arthroplasty
• Periprosthetic fractures
• Periprosthetic joint infection
• Implant fixation strategies
• Alignment controversies
• Outpatient joint replacement

Key debates include:

• Mechanical vs kinematic alignment
• Cemented vs cementless fixation
• Robotic-assisted arthroplasty
• Implant positioning optimization
• Enhanced recovery pathways

The revision arthroplasty sessions are particularly valuable, emphasizing multifactorial failure mechanisms and multidisciplinary reconstruction planning.

⚽ Sports Medicine & Arthroscopic Surgery

Sports medicine sessions explore contemporary management of:

• ACL injuries
• Rotator cuff tears
• Shoulder instability
• Cartilage restoration
• Arthroscopic bone grafting
• Skeletally immature athletes
• Return-to-play optimization

Faculty discuss how modern sports medicine increasingly incorporates:
✔️ Neuromuscular rehabilitation
✔️ Biomechanical restoration
✔️ Psychological readiness
✔️ Long-term joint preservation

Treatment approaches are compared across:

• Elite athletes
• Recreational patients
• Aging active populations

🦴 Spine Surgery & Complex Reconstruction

The spine curriculum reviews:

• Degenerative spine disease
• Spinal deformity correction
• Minimally invasive spine surgery
• Revision spine surgery
• Biologics in spinal reconstruction
• Technology-assisted alignment planning

Key themes include balancing:
✔️ Radiographic correction
✔️ Functional improvement
✔️ Long-term patient satisfaction

The course also highlights evolving interest in:

• Motion preservation
• Less invasive stabilization
• Enhanced perioperative recovery

💪 Shoulder, Elbow & Upper Extremity Surgery

Upper extremity surgery receives broad coverage throughout the program.

Topics include:

• Rotator cuff repair
• Shoulder arthroplasty
• Reverse shoulder arthroplasty
• Elbow reconstruction
• Wrist and hand reconstruction
• Arthroscopic instability surgery

Special attention is given to expanding indications for:
✔️ Reverse shoulder arthroplasty
✔️ Complex revision reconstruction
✔️ Fracture-related reconstruction

🚑 Orthopaedic Trauma & Fracture Care

Trauma-focused sessions emphasize:

• Intraoperative problem-solving
• Complex fracture fixation
• Trauma reconstruction
• Soft tissue management
• Surgical complications
• Perioperative decision-making

The trauma case series closely mirrors real-world surgical reasoning and emphasizes balancing:
✔️ Fixation stability
✔️ Soft tissue preservation
✔️ Patient physiology
✔️ Rehabilitation considerations

🦶 Foot & Ankle Reconstruction

The foot and ankle curriculum reviews:

• Complex instability
• Arthritic deformity correction
• Minimally invasive surgery
• Sports-related pathology
• Reconstructive procedures
• Advanced imaging integration

Faculty discuss how implant technology and deformity correction techniques continue transforming modern foot and ankle surgery.

🧬 Orthopaedic Oncology & Limb Salvage

Musculoskeletal oncology lectures cover:

• Limb salvage surgery
• Tumor reconstruction
• Biologic reconstruction strategies
• Multidisciplinary oncologic care

These sessions emphasize collaboration between:

• Orthopaedic oncology
• Plastic surgery
• Vascular surgery
• Rehabilitation medicine
• Oncology services

🤖 Orthobiologics, Robotics & AI in Orthopaedics

One of the most forward-looking components of the meeting involves emerging technology in orthopaedic surgery.

Topics include:

• Orthobiologics
• AI-assisted surgical planning
• Robotic arthroplasty
• Digital surgical platforms
• Wearable technology
• Biomedical devices

Faculty explore how data-driven orthopaedics may improve outcomes while also discussing:
✔️ Cost considerations
✔️ Workflow integration
✔️ Implementation challenges
✔️ Clinical realism vs technological hype

👨‍⚕️ Surgeon Wellness & Practice Management

Unlike many purely technical meetings, AAOS also addresses professional sustainability and healthcare systems.

Topics include:

• Surgeon burnout
• Career development
• Financial planning
• Mentorship
• Diversity and inclusion
• Healthcare economics
• Workplace professionalism

These sessions recognize that long-term surgical performance depends on:
✔️ Professional wellbeing
✔️ Leadership development
✔️ Sustainable practice environments

📚 Case-Based Learning Across Subspecialties

A defining strength of the program is its extensive case-based educational structure.

Case discussions span:

• Hip reconstruction
• Knee reconstruction
• Spine surgery
• Trauma
• Sports medicine
• Pediatrics
• Shoulder and elbow surgery
• Foot and ankle pathology
• Orthopaedic oncology

This format more accurately reflects the uncertainty and complexity of real clinical practice compared with traditional didactic lectures alone.

👨‍⚕️ Target Audience

This program is ideal for:

• Orthopaedic surgeons
• Arthroplasty specialists
• Sports medicine surgeons
• Spine surgeons
• Trauma surgeons
• Foot and ankle surgeons
• Shoulder and elbow specialists
• Orthopaedic oncologists
• Fellows and residents
• Musculoskeletal specialists

⭐ Why AAOS Annual Meeting On Demand 2026 Stands Out

✔️ One of the Largest Orthopaedic Education Libraries Available

Comprehensive coverage across all major orthopaedic subspecialties.

✔️ Combines Surgery + Technology + Systems-Based Care

Integrates procedural education with robotics, AI, biologics, rehabilitation, and healthcare delivery.

✔️ Strong Case-Based Learning Focus

Reflects real-world surgical complexity and clinical reasoning.

✔️ Covers Both Current Practice & Future Innovation

Addresses rapidly evolving technologies and treatment paradigms.

✔️ Excellent Resource for Ongoing Orthopaedic Education

Ideal for practicing surgeons, fellows, and advanced trainees.

🚀 Clinical Value

The AAOS Annual Meeting On Demand 2026 represents one of the most expansive orthopaedic educational resources currently available, offering advanced updates across:

• Arthroplasty
• Sports medicine
• Spine surgery
• Trauma
• Oncology
• Robotics
• Orthobiologics
• Digital orthopaedics
• Practice management

By combining:

• Technical surgical instruction
• Case-based decision-making
• Emerging technologies
• Multidisciplinary perspectives
• Evidence-based clinical updates

the program provides orthopaedic professionals with a comprehensive resource for modern musculoskeletal practice and lifelong surgical learning.